Uniqure NV rang the bell with a best-case scenario in the pivotal phase I/II study with AMT-130 for the treatment of ...

Sonomind SAS raised €3 million (US$ 3.5 million) in financing for its transcranial neuromodulation system, which targets deep regions within the brain non-invasively. The funds will go towards ...

A failed July inspection of manufacturer Catalent Indiana LLC has delayed another U.S. FDA approval, the latest being that of Scholar Rock Inc.’s selective anti-latent myostatin antibody, apitegromab, ...

The lack of funding available for early-stage European med-tech and AI-based companies could soon see many go under as their ...

The U.S. FDA approved Merck & Co. Inc.’s Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection on Sept. 19, ...

Celltrion Inc. announced plans to acquire from Eli Lilly and Co. a Branchburg, N.J.-based biologics cGMP facility for $330 ...

China’s National Medical Products Administration is arguably more active than regulatory agencies in many nations in ...

Pancreatic cancer remains one of the deadliest cancers, with survival rates showing little improvement over decades and ...

The Royal College of Psychiatrists in the U.K. has published its first-ever guidance to support research into psychedelic ...

Japan’s Pharmaceuticals and Medical Devices Agency has traditionally been less than receptive to clinical data from other ...

A recently published study in the Journal for Immunotherapy of Cancer presents a novel bispecific antibody-cytokine fusion ...

Mabwell Bioscience Co. Ltd. and Aditum Bio Management Co. LLC announced, in after-market hours Sept. 17, an agreement to ...